ARTICLE | Company News
Affinivax, Nosocomial Vaccine deal
November 16, 2015 8:00 AM UTC
Nosocomial Vaccine (NVC) partnered with Affinivax to develop vaccines to prevent nosocomial infections. The collaboration will utilize Affinivax’s Multiple Antigen Presentation System (MAPS) vaccine platform to develop the bacterial nosocomial infection vaccines. NVC will provide funding to develop candidates towards clinical testing. ...